Diagnostic findings and yield of investigations for children with developmental regression
Authors:
Open Access
- 27 March 2024
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 194 (8) , e63607
Abstract
Childhood conditions that feature developmental regression are poorly understood. Phenotype–genotype characterization and diagnostic yield data are needed to inform clinical decision‐making. The aim of this study was to report the conditions featuring developmental regression and assess diagnostic yields of investigations. A retrospective chart review of children presenting with developmental regression to a tertiary pediatric genetic clinic between 2018 and 2021 was performed. Of 99 children, 30% ( n = 30) had intellectual disability (ID), 21% ( n = 21) were autistic, 39% ( n = 39) were autistic with ID, and 9% ( n = 9) did not have ID or autism. Thirty‐two percent ( n = 32) of children received a new diagnosis, including eight molecular findings not previously reported to feature developmental regression. Of the children investigated, exome sequencing (ES) provided the highest diagnostic yield (51.1%, n = 24/47), highest (63.6%, n = 14/22) for children with ID, 50% for autistic children with ID ( n = 6/12) and children without autism or ID ( n = 3/6), and 14.3% ( n = 1/7) for autistic children without ID. We highlight the conditions that feature developmental regression and report on novel phenotypic expansions. The high diagnostic yield of ES, regardless of autism or ID diagnosis, indicates the presence of developmental regression as an opportunity to identify the cause, including for genetic differences not previously reported to include regression.Keywords
This publication has 36 references indexed in Scilit:
- Global developmental delay and intellectual disability in the era of genomics: Diagnosis and challenges in resource limited areasClinical Neurology and Neurosurgery, 2023
- Molecular Diagnostic Yield of Exome Sequencing and Chromosomal Microarray in Cerebral PalsyJAMA Neurology, 2022
- The diverse pleiotropic effects of spliceosomal protein PUF60: A case series of Verheij syndromeAmerican Journal of Medical Genetics Part A, 2022
- Novel Variants of the SMARCA4 Gene Associated with Autistic Features Rather Than Typical Coffin-Siris Syndrome in Eight Chinese Pediatric PatientsJournal of Autism and Developmental Disorders, 2021
- Prevalence and Age of Onset of Regression in Children with Autism Spectrum Disorder: A Systematic Review and Meta‐analytical UpdateAutism Research, 2021
- Management of Secondary Genomic FindingsThe American Journal of Human Genetics, 2020
- Developmental regression and mitochondrial function in children with autismAnnals of Clinical and Translational Neurology, 2020
- High Rate of Recurrent De Novo Mutations in Developmental and Epileptic EncephalopathiesThe American Journal of Human Genetics, 2017
- Systematic review of MRI findings in children with developmental delay or cognitive impairmentBrain and Development, 2017
- Consensus Statement: Chromosomal Microarray Is a First-Tier Clinical Diagnostic Test for Individuals with Developmental Disabilities or Congenital AnomaliesThe American Journal of Human Genetics, 2010